查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1454241

按疾病類型、治療類型、給藥途徑、分銷管道和地區分類的香港腳（足癬）的全球市場。

Global Athlete's Foot Market, By Disease Type, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography .
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年全球香港腳市場價值為14.1億足癬，預計2031年將達到20.6億美元，年複合成長率（CAGR）預計將成長4.8%。

報告範圍 報告詳情
基準年 2023年 2023/2024年市場規模 14.1億美元
實際資料 2019-2023 預測期 2024-2031
預測期2023/2024~2030/2031年複合成長率： 4.80% 2030/2031價值預測 20.6億美元
圖 1. 2024 年按地區分類的香港腳（足癬）全球市場佔有率（%）
全球腳氣市場-IMG1

香港腳（足癬腳）是一種常見的真菌感染疾病，會影響腳部皮膚，尤其是腳趾之間的皮膚，但也可能擴散到腳趾甲和手。這種真菌常見於運動員身上，因此被稱為香港腳（香港足癬），因為它在溫暖、潮濕的環境中生長，例如在運動員中很常見的出汗的鞋子中。這種情況的特徵是腳趾間和腳底發癢、刺痛和灼熱感。受影響的皮膚可能會變紅、粗糙、破裂和起水泡。雖然令人不快，但症狀通常很輕微，可以用非處方抗真菌藥物治療。在持續或嚴重的情況下，可能需要更積極的處方箋治療。香港腳（足癬）是由皮癬菌（一種生長在皮膚壞死表皮中的真菌）引起的。這種真菌很容易透過直接接觸受污染的表面以及間接接觸毛巾、鞋子和衣服等物品傳播。社區淋浴設備、游泳池和更衣室是感染的熱點，運動員和健身愛好者尤其容易受到感染。足部衛生對於預防香港腳（足癬腳）起著重要作用。這包括保持足部清潔乾燥、穿透氣的鞋子、定期更換襪子、不要赤腳在可能存在真菌的公共場所行走等。患有香港腳（足癬腳）的人也需要小心，不要將感染傳播到身體的其他部位或傳染給其他人。早期發現和治療香港腳（足癬）對於防止感染疾病變得難以控制或導致更嚴重的繼發細菌感染非常重要。了解原因、預防和治療方案可以幫助您有效應對這種情況並保持足部健康。

市場動態：

全球香港腳（足癬）市場主要是由於老年人口增加、肥胖率上升以及水上活動參與度增加而導致感染疾病率上升。人們對未經治療的足部真菌感染疾病的影響的健康認知不斷提高，這也推動了自我診斷和非成藥的發展。然而，其他治療選擇，例如使用非處方藥 (OTC) 外用乳膏和粉末的家庭療法，可能會阻礙處方藥的產生收入潛力。

本研究的主要特點

  • 該報告對全球香港腳（足癬）市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。
  • 它還說明了各個細分市場的潛在商機，並為該市場提供了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
  • 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球香港腳（足癬）市場的主要企業。
  • 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球香港腳（足癬）市場報告迎合了該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球香港腳（足癬）市場的各種策略矩陣，將有助於相關人員做出決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
  • 提高健康和衛生意識
  • 個人護理和運動保健支出增加
  • 治療方案的技術進步
  • 主要亮點
  • 監管場景
  • 最近的趨勢
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 合併、收購和合作

第4章全球香港腳（足癬）市場－冠狀病毒（COVID-19）大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章2019-2031年全球香港腳（足癬）市場，依藥物類別

  • 抗真菌藥物
  • 組合使用

第6章2019-2031年全球香港腳（足癬）市場（依疾病適應症）

  • 中足
  • 腳底
  • 水痘的

第 7 章 全球香港腳（足癬）市場，途徑分類，2019-2031 年

  • 外用
  • 口服

第8章2019-2031年全球香港腳市場（依足癬通路）

  • 醫院藥房
  • 零售藥房
  • 網路藥房

第9章2019- 足癬年全球香港腳市場（按地區）

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第10章競爭格局

  • 公司簡介
    • Perrigo Company Plc.
    • Novartis AG
    • Valeant Pharmaceuticals International
    • GlaxoSmithKline plc
    • Bayer AG
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan NV
    • Glenmark Pharmaceutical Ltd
    • Taro Pharmaceutical Industries Ltd.
    • Camber Pharmaceuticals Inc
    • Aurobindo Pharma Ltd

第11章 章節

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6665

The global athlete's foot market was valued at US$ 1.41 Bn in 2023 and is expected to reach US$ 2.06 Bn by 2031, growing at a compound annual growth rate (CAGR) of 4.8% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 1.41 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 4.80% 2030/2031 Value Projection: US$ 2.06 Bn
Figure 1. Global Athlete's Foot Market Share (%), By Region, 2024
Global Athlete's Foot Market - IMG1

Athlete's foot, also known as tinea pedis, is a common fungal infection that affects the skin on the feet, particularly the spaces between the toes, but can also spread to the toenails and hands. It is named ""athlete's foot"" because it is frequently seen in athletes, as the fungus thrives in warm, moist environments, such as the inside of sweaty shoes, which are common among sports participants. This condition is characterized by itching, stinging, and burning sensations between the toes or on the soles of the feet. The affected skin may also become red, flaky, cracked, or blistered. Although the condition can be uncomfortable, it is generally mild and can be treated with over-the-counter antifungal medications. In persistent or severe cases, prescription-strength treatments may be necessary. Athlete's foot is caused by dermatophytes, a type of fungus that grows on the dead outer layer of skin. The fungus spreads easily through direct contact with contaminated surfaces or through indirect contact with towels, shoes, or clothing. Communal showers, swimming pools, and locker rooms are hotspots for transmission, making athletes and gym-goers particularly susceptible. Good foot hygiene plays a crucial role in preventing athlete's foot. This includes keeping the feet clean and dry, wearing breathable footwear, changing socks regularly, and avoiding walking barefoot in public places where the fungus may be present. Individuals with athlete's foot should also be careful not to spread the infection to other parts of their body or to other people. Early detection and treatment of athlete's foot are important to prevent the infection from becoming more difficult to manage or leading to more serious secondary bacterial infections. Understanding the causes, prevention, and treatment options enables individuals to effectively deal with this condition and maintain good foot health.

Market Dynamics:

The global athlete's foot market is primarily driven by the rising prevalence of the infection due to a growing geriatric population, increasing obesity rates, and greater participation in aquatic activities. Growing health awareness regarding implications of untreated fungal infections of feet is also supporting self-diagnosis and over-the-counter medication. However, alternative treatment options such as home remedies using over-the-counter (OTC) topical creams and powders may hinder revenue generation potential for prescription drugs.

Key features of the study:

  • This report provides in-depth analysis of the global athlete's foot market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global athlete's foot market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Perrigo Company Plc., Novartis AG, Valeant Pharmaceuticals International, GlaxoSmithKline plc, Bayer AG, Teva Pharmaceuticals Industries Ltd., Mylan NV, Glenmark Pharmaceutical Ltd, Taro Pharmaceutical Industries Ltd., Camber Pharmaceuticals Inc, Aurobindo Pharma Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global athlete's foot market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global athlete's foot market

Detailed Segmentation:

  • Global Athlete's Foot Market, By Drug Class
    • Antifungals
    • Combination
  • Global Athlete's Foot Market, By Disease Indication
    • Interdigital
    • Plantar
    • Vesicular
  • Global Athlete's Foot Market, By Route of Administration
    • Topical
    • Oral
  • Global Athlete's Foot Market, By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Athlete's Foot Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Top Companies in Global Athlete's Foot Market:
    • Perrigo Company Plc.
    • Novartis AG
    • Valeant Pharmaceuticals International
    • GlaxoSmithKline plc
    • Bayer AG
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan NV
    • Glenmark Pharmaceutical Ltd
    • Taro Pharmaceutical Industries Ltd.
    • Camber Pharmaceuticals Inc
    • Aurobindo Pharma Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Athlete's Foot, By Drug Class
    • Market Athlete's Foot, By Disease Indication
    • Market Athlete's Foot, By Route of Administration
    • Market Athlete's Foot, By Distribution Channel
    • Market Athlete's Foot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
  • Growing health and hygiene awareness
  • Increasing spending on personal care and sports healthcare
  • Technological advancements in treatment options
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Athlete's Foot Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Athlete's Foot Market, By Drug Class, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Antifungals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Combination
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Athlete's Foot Market, By Disease Indication, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Interdigital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Plantar
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Vesicular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Athlete's Foot Market, By Route of Administration, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Segment Trends
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Athlete's Foot Market, By Distribution Channel, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

9. Global Athlete's Foot Market, By Region, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Country 2019 -2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

10. Competitive Landscape

  • Company Profile
    • Perrigo Company Plc.
  • Drug Class Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Novartis AG
    • Valeant Pharmaceuticals International
    • GlaxoSmithKline plc
    • Bayer AG
    • Teva Pharmaceuticals Industries Ltd.
    • Mylan NV
    • Glenmark Pharmaceutical Ltd
    • Taro Pharmaceutical Industries Ltd.
    • Camber Pharmaceuticals Inc
    • Aurobindo Pharma Ltd

Analyst Views

11. Section

  • References
  • Research Methodology
  • About us